Skip to main content
Journal cover image

Low-density lipoprotein cholesterol level and statin use among Medicare beneficiaries with diabetes mellitus.

Publication ,  Journal Article
Qualls, LG; Hammill, BG; Maciejewski, ML; Curtis, LH; Jones, WS
Published in: Diab Vasc Dis Res
May 2016

At the time of this study, guidelines recommended a primary goal of low-density lipoprotein cholesterol level less than 100 mg/dL for all patients, an optional goal of low-density lipoprotein cholesterol less than 70 mg/dL for patients with overt cardiovascular disease and statins for patients with diabetes and overt cardiovascular disease and patients 40 years and older with diabetes and at least one risk factor for cardiovascular disease. This study examined statin use and achievement of lipid goals among 111,730 Medicare fee-for-service beneficiaries 65 years and older in 2011. Three-quarters of patients met the low-density lipoprotein cholesterol goal of less than 100 mg/dL. Patients with cardiovascular disease were more likely to meet the goal than those without, not controlling for other differences. Patients on a statin were more likely to meet the goal. There is considerable opportunity for improvement in cholesterol management in high-risk patients with diabetes mellitus.

Duke Scholars

Published In

Diab Vasc Dis Res

DOI

EISSN

1752-8984

Publication Date

May 2016

Volume

13

Issue

3

Start / End Page

244 / 246

Location

England

Related Subject Headings

  • United States
  • Treatment Outcome
  • Time Factors
  • Risk Factors
  • Risk Assessment
  • Process Assessment, Health Care
  • Prevalence
  • Medicare
  • Male
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Qualls, L. G., Hammill, B. G., Maciejewski, M. L., Curtis, L. H., & Jones, W. S. (2016). Low-density lipoprotein cholesterol level and statin use among Medicare beneficiaries with diabetes mellitus. Diab Vasc Dis Res, 13(3), 244–246. https://doi.org/10.1177/1479164115620980
Qualls, Laura G., Bradley G. Hammill, Matthew L. Maciejewski, Lesley H. Curtis, and W Schuyler Jones. “Low-density lipoprotein cholesterol level and statin use among Medicare beneficiaries with diabetes mellitus.Diab Vasc Dis Res 13, no. 3 (May 2016): 244–46. https://doi.org/10.1177/1479164115620980.
Qualls LG, Hammill BG, Maciejewski ML, Curtis LH, Jones WS. Low-density lipoprotein cholesterol level and statin use among Medicare beneficiaries with diabetes mellitus. Diab Vasc Dis Res. 2016 May;13(3):244–6.
Qualls, Laura G., et al. “Low-density lipoprotein cholesterol level and statin use among Medicare beneficiaries with diabetes mellitus.Diab Vasc Dis Res, vol. 13, no. 3, May 2016, pp. 244–46. Pubmed, doi:10.1177/1479164115620980.
Qualls LG, Hammill BG, Maciejewski ML, Curtis LH, Jones WS. Low-density lipoprotein cholesterol level and statin use among Medicare beneficiaries with diabetes mellitus. Diab Vasc Dis Res. 2016 May;13(3):244–246.
Journal cover image

Published In

Diab Vasc Dis Res

DOI

EISSN

1752-8984

Publication Date

May 2016

Volume

13

Issue

3

Start / End Page

244 / 246

Location

England

Related Subject Headings

  • United States
  • Treatment Outcome
  • Time Factors
  • Risk Factors
  • Risk Assessment
  • Process Assessment, Health Care
  • Prevalence
  • Medicare
  • Male
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors